• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒疫苗诱导的心肌炎

Covid- 19 Vaccine-induced Myocarditis.

作者信息

Munjal Jaskaran S, Flores Sergio M, Yousuf Hamza, Gupta Vasu, Munjal Ripudaman S, Anamika Fnu, Mendpara Vaidehi, Shah Priyanshi, Jain Rohit

机构信息

Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly, Uttar Pradesh, India.

University of Monterrey, Mexico.

出版信息

J Community Hosp Intern Med Perspect. 2023 Sep 2;13(5):44-49. doi: 10.55729/2000-9666.1229. eCollection 2023.

DOI:10.55729/2000-9666.1229
PMID:37868673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10589044/
Abstract

Myocarditis and pericarditis are rare adverse reactions, more commonly seen in young males after receiving the second dose of an mRNA vaccine. However, the benefits of vaccination heavily outweigh the risk of these side effects. In addition, vaccination boosters are effective against the newest, more infective variants. Therefore we expect more vaccines to be administered in the following years. The objective of this study is to review the current understanding of the mechanism, diagnosis, and treatment of myocarditis and pericarditis. Proposed mechanisms include molecular mimicry against the S protein and hypersensitivity reactions with mRNA vaccines and platelet aggregation and thrombus formation in cardiac blood vessels with adenoviral vaccines. Diagnosis of myocarditis is based on clinical findings, cardiac enzymes, ECG, MRI, and echocardiographic findings. Management includes NSAIDs and cardiovascular support in selected cases with ventricular dysfunction. Most patients have a mild presentation with preservation of cardiac function and recover entirely within seven days; the average hospital stay is three days. Long-term complications are infrequent.

摘要

心肌炎和心包炎是罕见的不良反应,在年轻男性接种第二剂mRNA疫苗后更为常见。然而,接种疫苗的益处远远超过这些副作用的风险。此外,加强接种疫苗对最新、传染性更强的变异毒株有效。因此,我们预计在未来几年会有更多疫苗接种。本研究的目的是综述目前对心肌炎和心包炎的发病机制、诊断及治疗的认识。提出的机制包括针对S蛋白的分子模拟以及mRNA疫苗引发的超敏反应,还有腺病毒疫苗导致的心脏血管内血小板聚集和血栓形成。心肌炎的诊断基于临床表现、心肌酶、心电图、磁共振成像和超声心动图检查结果。治疗包括在部分出现心室功能障碍的病例中使用非甾体抗炎药并给予心血管支持。大多数患者表现轻微,心脏功能得以保留,且在七天内完全康复;平均住院时间为三天。长期并发症并不常见。

相似文献

1
Covid- 19 Vaccine-induced Myocarditis.新冠病毒疫苗诱导的心肌炎
J Community Hosp Intern Med Perspect. 2023 Sep 2;13(5):44-49. doi: 10.55729/2000-9666.1229. eCollection 2023.
2
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.新型冠状病毒肺炎(COVID-19)疫苗接种后心肌炎和心包炎的发生率、危险因素、自然史和假设发病机制:基于实时证据的综合分析和综述。
BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445.
3
Acute Myocarditis and Pericarditis After mRNA COVID-19 Vaccinations-A Single-Centre Retrospective Analysis.mRNA COVID-19 疫苗接种后急性心肌炎和心包炎:一项单中心回顾性分析。
Heart Lung Circ. 2023 Apr;32(4):467-479. doi: 10.1016/j.hlc.2023.01.002. Epub 2023 Feb 24.
4
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand.泰国新冠疫苗接种后的心肌炎和心包炎
Vaccines (Basel). 2023 Mar 28;11(4):749. doi: 10.3390/vaccines11040749.
5
Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.mRNA COVID-19 疫苗接种后的心脏并发症:病例报告和病例系列的系统评价。
Rev Med Virol. 2022 Jul;32(4):e2318. doi: 10.1002/rmv.2318. Epub 2021 Dec 17.
6
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.意大利 12 至 39 岁人群接种 COVID-19 mRNA 疫苗后的心肌炎和心包炎上市后主动监测:多数据库、自身对照病例系列研究。
PLoS Med. 2022 Jul 28;19(7):e1004056. doi: 10.1371/journal.pmed.1004056. eCollection 2022 Jul.
7
The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.mRNA COVID-19 疫苗接种后心肌炎和心包炎的极低风险不应阻止疫苗接种。
Swiss Med Wkly. 2021 Oct 19;151:w30087. doi: 10.4414/smw.2021.w30087. eCollection 2021 Oct 11.
8
Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination-A nationwide study.COVID-19 mRNA 疫苗接种后心肌炎和心包炎的风险:一项全国性研究。
J Microbiol Immunol Infect. 2023 Jun;56(3):558-565. doi: 10.1016/j.jmii.2023.01.016. Epub 2023 Feb 8.
9
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.mRNA COVID-19 疫苗接种后出现心肌炎报告:免疫实践咨询委员会更新-美国,2021 年 6 月。
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2.
10
The benefit of vaccination against COVID-19 outweighs the potential risk of myocarditis and pericarditis.接种新冠疫苗的益处大于心肌炎和心包炎的潜在风险。
Neth Heart J. 2022 Apr;30(4):190-197. doi: 10.1007/s12471-022-01677-9. Epub 2022 Mar 9.

引用本文的文献

1
Older Age as a Predictor of Ongoing Active Changes in Follow-Up Cardiac Magnetic Resonance in Children with Acute Myocarditis.年龄较大作为急性心肌炎患儿随访心脏磁共振成像中持续活动性改变的预测因素
J Clin Med. 2024 Oct 30;13(21):6498. doi: 10.3390/jcm13216498.
2
Myocarditis Associated with COVID-19 Vaccination.与新冠病毒疫苗接种相关的心肌炎
Vaccines (Basel). 2024 Oct 19;12(10):1193. doi: 10.3390/vaccines12101193.
3
The Ambivalence of Post COVID-19 Vaccination Responses in Humans.人类对 COVID-19 疫苗接种反应的矛盾心理。

本文引用的文献

1
Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.加拿大安大略省青少年和成年人中,基于疫苗产品、接种程序和剂间间隔的 mRNA 疫苗接种后心肌炎和心包炎的流行病学。
JAMA Netw Open. 2022 Jun 1;5(6):e2218505. doi: 10.1001/jamanetworkopen.2022.18505.
2
Imaging of Myocarditis Following mRNA COVID-19 Booster Vaccination.mRNA新冠疫苗加强针接种后心肌炎的影像学表现
Radiol Cardiothorac Imaging. 2022 Mar 10;4(2):e220019. doi: 10.1148/ryct.220019. eCollection 2022 Apr.
3
COVID-19 Vaccination and Estimated Public Health Impact in California.
Biomolecules. 2024 Oct 17;14(10):1320. doi: 10.3390/biom14101320.
4
Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies.由新冠病毒mRNA疫苗接种、SARS-CoV-2感染或传统病因引起的心肌炎患者的长期预后
JAMA. 2024 Aug 26;332(16):1367-77. doi: 10.1001/jama.2024.16380.
5
Genome-wide association study of BNT162b2 vaccine-related myocarditis identifies potential predisposing functional areas in Hong Kong adolescents.香港青少年 BNT162b2 疫苗相关心肌炎的全基因组关联研究确定了潜在的易患功能区域。
BMC Genom Data. 2024 Jun 6;25(1):51. doi: 10.1186/s12863-024-01238-6.
COVID-19 疫苗接种和加利福尼亚州的预估公共卫生影响。
JAMA Netw Open. 2022 Apr 1;5(4):e228526. doi: 10.1001/jamanetworkopen.2022.8526.
4
Myocarditis following AstraZeneca (an adenovirus vector vaccine) COVID-19 vaccination: A case report.阿斯利康(腺病毒载体疫苗)新冠疫苗接种后发生的心肌炎:一例病例报告。
Clin Case Rep. 2022 Apr 15;10(4):e05744. doi: 10.1002/ccr3.5744. eCollection 2022 Apr.
5
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.在全国范围内接种第四剂 BNT162b2 mRNA 新冠疫苗。
N Engl J Med. 2022 Apr 28;386(17):1603-1614. doi: 10.1056/NEJMoa2201688. Epub 2022 Apr 13.
6
COVID-19 and myocarditis: a review of literature.新型冠状病毒肺炎与心肌炎:文献综述
Egypt Heart J. 2022 Apr 5;74(1):23. doi: 10.1186/s43044-022-00260-2.
7
Cardiovascular Complications of COVID-19 Vaccines.新冠疫苗的心血管并发症
Front Cardiovasc Med. 2022 Mar 18;9:840929. doi: 10.3389/fcvm.2022.840929. eCollection 2022.
8
COVID-19-Vaccination-Induced Myocarditis in Teenagers: Case Series with Further Follow-Up.青少年中新冠病毒疫苗接种诱发的心肌炎:进一步随访的病例系列
Int J Environ Res Public Health. 2022 Mar 15;19(6):3456. doi: 10.3390/ijerph19063456.
9
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.BNT162b2 新冠病毒疫苗第三剂的安全性和有效性。
N Engl J Med. 2022 May 19;386(20):1910-1921. doi: 10.1056/NEJMoa2200674. Epub 2022 Mar 23.
10
Hypersensitivity Myocarditis and the Pathogenetic Conundrum of COVID-19 Vaccine-Related Myocarditis.超敏性心肌炎与新冠疫苗相关心肌炎的发病机制难题
Cardiology. 2022;147(4):413-415. doi: 10.1159/000524224. Epub 2022 Mar 22.